Cited by 84Tissue Engineering and Regenerative MedicineHydrogels: synthesis, properties, applicationsAdvanced Drug Delivery Systems

VEGF-loaded microsphere patch for local protein delivery to the ischemic heart

Rodness, Jonathan, Mihic, Anton, Miyagi, Yasuo, Wu, Jun, Weisel, Richard D., Li, Ren-Ke·2016·Acta Biomaterialia

Abstract

Background Revascularization of the heart after myocardial infarction (MI) using growth factors delivered by hydrogel-based microspheres represents a promising therapeutic approach for cardiac regeneration. Microspheres have tuneable degradation properties and support the prolonged release of soluble factors. Cardiac patches provide mechanical restraint, preventing dilatation associated with ventricular remodelling.Methods We combined these approaches and produced a compacted calcium-alginate microsphere patch, restrained by a chitosan sheet, to deliver vascular endothelial growth factor (VEGF) to the heart after myocardial injury in rats.Results Microspheres had an average diameter of 3.2μm, were nonporous, and characterized by a smooth dimpled surface. Microsphere patches demonstrated prolonged in vitro release characteristics compared to non-compacted microspheres and VEGF supernatants obtained from patches maintained their bioactivity for the 5day duration of the study in vitro. In vivo, patches were assessed with magnetic resonance imaging following MI, and demonstrated 50% degradation 25.6days after implantation. Both VEGF(-) and VEGF(+) microsphere patch-treated hearts had better cardiac function than unpatched (chitosan sheet only) controls. However, VEGF(+) microsphere-patched hearts had thicker scars characterized by higher capillary density in the border zone than did those treated with VEGF(-) patches. VEGF was detected in the patches 4weeks post-implantation.Conclusion The condensed microsphere patch represents a new therapeutic platform for cytokine delivery and could be used as an adjuvant to current biomaterial and cell-based therapies to promote localized angiogenesis in the infarcted heart.Statement of significance Following a heart attack, a lack of blood flow to the heart results in loss of heart cells. Growth factors may facilitate growth of blood vessels and heart tissue repair and prevent the onset of heart failure. Determining a way to deliver these growth factors directly to the heart is vital. Here, we combined two biomaterial-based approaches to deliver vascular endothelial growth factor (VEGF) to rat hearts after heart attack: a microsphere for prolonged release of VEGF, and a cardiac patch for mechanical restraint to prevent heart dysfunction. The feasibility of this microsphere patch was demonstrated by surgically implanting it over the infarct region of the heart post-injury. VEGF-patched hearts had better blood vessel growth, tissue repair, and heart function.

Integrity signals

Registry

Crossref · 10.1016/j.actbio.2016.09.009

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Heart patch can be used as carrier to slowly release growth factors such as VEGF and bFGF to promote angiogenesis and tissue regeneration.

    “it can be used as a carrier to slowly release growth factors such as VEGF and bFGF to promote angiogenesis and tissue regeneration [165].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rodness, J., Mihic, A., Miyagi, Y., Wu, J., Weisel, R. D., & Li, R.-K.
Affiliations
University Health Network (CA)
Corresponding author
Li, Ren-Ke
Venue
Acta Biomaterialia
Publisher
Elsevier BV
Published
2016-11
Volume
45
Pages
169-181
ISSN
1742-7061 (ISSN-L)
OpenAlex
W2519983187
Cited by
84
References
35
Citations by year
2026: 9 · 2025: 8 · 2024: 8 · 2023: 6 · 2022: 7 · 2021: 12 · 2020: 12 · 2019: 12 · 2018: 6 · 2017: 4
FWCI
8.11
Type
journal article
Language
en
Open access
closed
Locations
  • Acta Biomaterialia (publishedVersion)
  • PubMed (publishedVersion)
Funders
Heart and Stroke Foundation of Canada (G140005765)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Hydrogels: synthesis, properties, applications
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
vascular endothelial growth factor, calcium alginate microspheres, myocardial infarction, local growth factor delivery, cardiac regeneration, angiogenesis, ventricular remodeling, sustained drug release, cardiac patch, infarct border zone, cardiac function
MeSH terms
Alginates, Animals, Biocompatible Materials, Calcium, Female, Hexuronic Acids, Humans, Microspheres, Pericardium, Drug Delivery Systems, Myocardial Ischemia, Rats, Sprague-Dawley, Neovascularization, Physiologic, Implants, Experimental, Glucuronic Acid, Vascular Endothelial Growth Factor A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review